A citation-based method for searching scientific literature

Yong Luo, Chaolong Lin, Yidi Zou, Fei Ju, Wenfeng Ren, Yanhua Lin, Yale Wang, Xiaoxuan Huang, Huiling Liu, Zeng Yu, Pingguo Liu, Guowei Tan, Quan Yuan, Jun Zhang, Chenghao Huang, Ningshao Xia. Oncoimmunology 2020
Times Cited: 2







List of co-cited articles
8 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mesenchymal stem cells as carriers for systemic delivery of oncolytic viruses.
Agata Hadryś, Aleksander Sochanik, Grant McFadden, Joanna Jazowiecka-Rakus. Eur J Pharmacol 2020
20
100

Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model.
Esther Rincón, Teresa Cejalvo, Deepak Kanojia, Arantzazu Alfranca, Miguel Ángel Rodríguez-Milla, Raul Andrés Gil Hoyos, Yu Han, Lingjiao Zhang, Ramón Alemany, Maciej S Lesniak,[...]. Oncotarget 2017
29
100

Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas.
Wanlu Du, Ivan Seah, Oumaima Bougazzoul, GiHun Choi, Katrina Meeth, Marcus W Bosenberg, Hiroaki Wakimoto, David Fisher, Khalid Shah. Proc Natl Acad Sci U S A 2017
41
100

Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases.
Valerio Leoni, Valentina Gatta, Arianna Palladini, Giordano Nicoletti, Dario Ranieri, Massimiliano Dall'Ora, Valentina Grosso, Martina Rossi, Francesco Alviano, Laura Bonsi,[...]. Oncotarget 2015
40
100

First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced Tumors.
David Ruano, José A López-Martín, Lucas Moreno, Álvaro Lassaletta, Francisco Bautista, Maitane Andión, Carmen Hernández, África González-Murillo, Gustavo Melen, Ramón Alemany,[...]. Mol Ther 2020
23
100

Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy.
Khaphetsi Joseph Mahasa, Lisette de Pillis, Rachid Ouifki, Amina Eladdadi, Philip Maini, A-Rum Yoon, Chae-Ok Yun. Sci Rep 2020
17
100


Systemic oncolytic adenovirus delivered in mesenchymal carrier cells modulate tumor infiltrating immune cells and tumor microenvironment in mice with neuroblastoma.
Lidia Franco-Luzón, África González-Murillo, Cristina Alcántara-Sánchez, Lorena García-García, Maryam Tabasi, Ana Luis Huertas, Louis Chesler, Manuel Ramírez. Oncotarget 2020
12
100

Immunomodulation of endothelial differentiated mesenchymal stromal cells: impact on T and NK cells.
Reine El Omar, Yu Xiong, Gabriel Dostert, Huguette Louis, Monique Gentils, Patrick Menu, Jean-François Stoltz, Émilie Velot, Véronique Decot. Immunol Cell Biol 2016
15
50

Isolation and Characterisation of Human Adipose-Derived Stem Cells.
Anna Wilson, Melisse Chee, Peter Butler, Ashleigh S Boyd. Methods Mol Biol 2019
1
100

Tropism of mesenchymal stem cell toward CD133+ stem cell of glioblastoma in vitro and promote tumor proliferation in vivo.
Lorena Favaro Pavon, Tatiana Tais Sibov, Andrea Vieira de Souza, Edgar Ferreira da Cruz, Suzana M F Malheiros, Francisco Romero Cabral, Jean Gabriel de Souza, Pamela Boufleur, Daniela Mara de Oliveira, Silvia Regina Caminada de Toledo,[...]. Stem Cell Res Ther 2018
30
50

Mesenchymal Stromal Cells for Linked Delivery of Oncolytic and Apoptotic Adenoviruses to Non-small-cell Lung Cancers.
Valentina Hoyos, Francesca Del Bufalo, Shigeki Yagyu, Miki Ando, Gianpietro Dotti, Masataka Suzuki, Lisa Bouchier-Hayes, Ramon Alemany, Malcolm K Brenner. Mol Ther 2015
15
50

Current understanding of reovirus oncolysis mechanisms.
Matthew B Phillips, Johnasha D Stuart, Roxana M Rodríguez Stewart, Jameson Tl Berry, Bernardo A Mainou, Karl W Boehme. Oncolytic Virother 2018
26
50

Efficacy of Talimogene Laherparepvec (T-VEC) Therapy in Patients with In-Transit Melanoma Metastasis Decreases with Increasing Lesion Size.
Sabran J Masoud, Janice B Hu, Georgia M Beasley, John H Stewart, Paul J Mosca. Ann Surg Oncol 2019
16
50

STAT3 Contributes To Oncolytic Newcastle Disease Virus-Induced Immunogenic Cell Death in Melanoma Cells.
Xiaoyan Shao, Xueke Wang, Xianling Guo, Ke Jiang, Tian Ye, Jianhua Chen, Juemin Fang, Linaer Gu, Sitong Wang, Guirong Zhang,[...]. Front Oncol 2019
11
50


Inflammatory Chemokines MIP-1δ and MIP-3α Are Involved in the Migration of Multipotent Mesenchymal Stromal Cells Induced by Hepatoma Cells.
Esma Lejmi, Nadja Perriraz, Sophie Clément, Philippe Morel, Reto Baertschiger, Panayiotis Christofilopoulos, Raphael Meier, Domenico Bosco, Léo H Bühler, Carmen Gonelle-Gispert. Stem Cells Dev 2015
19
50

Evaluation of Newcastle disease virus mediated dendritic cell activation and cross-priming tumor-specific immune responses ex vivo.
Qi Xu, Udaya S Rangaswamy, Weijia Wang, Scott H Robbins, James Harper, Hong Jin, Xing Cheng. Int J Cancer 2020
4
50

Analysis of Immunological Treatment Effects of Virotherapy in Tumor Tissue.
Krishna Das, Carles Urbiola, Bart Spiesschaert, Philipp Mueller, Guido Wollmann. Methods Mol Biol 2020
1
100

Patient-derived mesenchymal stem cells as delivery vehicles for oncolytic virotherapy: novel state-of-the-art technology.
Manuel Ramírez, Javier García-Castro, Gustavo J Melen, África González-Murillo, Lidia Franco-Luzón. Oncolytic Virother 2015
18
50

Mesenchymal Stem Cell-Mediated Delivery of an Oncolytic Adenovirus Enhances Antitumor Efficacy in Hepatocellular Carcinoma.
A-Rum Yoon, JinWoo Hong, Yan Li, Ha Chul Shin, Hyunah Lee, Hyun Soo Kim, Chae-Ok Yun. Cancer Res 2019
28
50

Cellular Virotherapy Increases Tumor-Infiltrating Lymphocytes (TIL) and Decreases their PD-1+ Subsets in Mouse Immunocompetent Models.
Alvaro Morales-Molina, Miguel Ángel Rodríguez-Milla, Alicia Gimenez-Sanchez, Ana Judith Perisé-Barrios, Javier García-Castro. Cancers (Basel) 2020
4
50


Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy.
Volker Schirrmacher, Stefaan van Gool, Wilfried Stuecker. Biomedicines 2019
23
50

Adaptive antiviral immunity is a determinant of the therapeutic success of oncolytic virotherapy.
Paul T Sobol, Jeanette E Boudreau, Kyle Stephenson, Yonghong Wan, Brian D Lichty, Karen L Mossman. Mol Ther 2011
67
50

Application of mesenchymal stem cells as a vehicle to deliver replication-competent adenovirus for treating malignant glioma.
Cui Hai, Yong-Min Jin, Wen-Biao Jin, Zhe-Zhu Han, Mei-Nv Cui, Xue-Zhe Piao, Xiong-Hu Shen, Song-Nan Zhang, Hong-Hua Sun. Chin J Cancer 2012
9
50

Oncolytic viruses: how "lytic" must they be for therapeutic efficacy?
Maria Eugenia Davola, Karen Louise Mossman. Oncoimmunology 2019
42
50

TNFa and IL2 Encoding Oncolytic Adenovirus Activates Pathogen and Danger-Associated Immunological Signaling.
Camilla Heiniö, Riikka Havunen, Joao Santos, Klaas de Lint, Victor Cervera-Carrascon, Anna Kanerva, Akseli Hemminki. Cells 2020
13
50

Mesenchymal stem cells alter the frequency and cytokine profile of natural killer cells in abortion-prone mice.
Fatemeh Rezaei Kahmini, Shahab Shahgaldi, Seyed Mohammad Moazzeni. J Cell Physiol 2020
5
50

Human mesenchymal stem cells modulate B-cell functions.
Anna Corcione, Federica Benvenuto, Elisa Ferretti, Debora Giunti, Valentina Cappiello, Francesco Cazzanti, Marco Risso, Francesca Gualandi, Giovanni Luigi Mancardi, Vito Pistoia,[...]. Blood 2006
50

The Inhibitory Effect of Mesenchymal Stem Cells with rAd-NK4 on Liver Cancer.
Chao Cai, Lingling Hou, Jingsi Zhang, Diandian Zhao, Ziling Wang, Honggang Hu, Jinsheng He, Weijun Guan, Yuehui Ma. Appl Biochem Biotechnol 2017
11
50

Impaired mRNA Expression of the Migration Related Chemokine Receptor CXCR4 in Mesenchymal Stem Cells of COPD Patients.
K Karagiannis, A Proklou, E Tsitoura, I Lasithiotaki, C Kalpadaki, D Moraitaki, I Sperelakis, G Kontakis, K M Antoniou, N Tzanakis. Int J Inflam 2017
7
50

Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series.
Lillian Sun, Pauline Funchain, Jung Min Song, Patricia Rayman, Charles Tannenbaum, Jennifer Ko, Michael Mcnamara, C Marcela Diaz-Montero, Brian Gastman. J Immunother Cancer 2018
47
50

Human Adipose Tissue-Derived Mesenchymal Stem Cells Target Brain Tumor-Initiating Cells.
Seung Ah Choi, Ji Yeoun Lee, Sung Eun Kwon, Kyu-Chang Wang, Ji Hoon Phi, Jung Won Choi, Xiong Jin, Ja Yun Lim, Hyunggee Kim, Seung-Ki Kim. PLoS One 2015
20
50


Kinetics of Oncolytic Reovirus T3D Replication and Growth Pattern in Mesenchymal Stem Cells.
Razieh Sadat Banijamali, Hoorieh Soleimanjahi, Sara Soudi, Hesam Karimi, Asghar Abdoli, Seyed Mahmood Seyed Khorrami, Keivan Zandi. Cell J 2020
7
50

Mesenchymal Stromal Cell-Derived Exosomes Affect mRNA Expression and Function of B-Lymphocytes.
Drirh Khare, Reuven Or, Igor Resnick, Claudine Barkatz, Osnat Almogi-Hazan, Batia Avni. Front Immunol 2018
42
50

Mesenchymal stem cell homing towards cancer cells is increased by enzyme activity of cathepsin D.
Gowthami Vangala, Floriane M Imhoff, Chloe M L Squires, Andrew G Cridge, Sarah K Baird. Exp Cell Res 2019
4
50

Talimogene laherparepvec: overview, combination therapy and current practices.
Cristina O'Donoghue, Matthew P Doepker, Jonathan S Zager. Melanoma Manag 2016
5
50

Intratumoral Immunotherapy-Update 2019.
Omid Hamid, Rubina Ismail, Igor Puzanov. Oncologist 2020
15
50

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death.
Abhishek D Garg, Lorenzo Galluzzi, Lionel Apetoh, Thais Baert, Raymond B Birge, José Manuel Bravo-San Pedro, Karine Breckpot, David Brough, Ricardo Chaurio, Mara Cirone,[...]. Front Immunol 2015
199
50

Advances in Anti-Cancer Immunotherapy: Car-T Cell, Checkpoint Inhibitors, Dendritic Cell Vaccines, and Oncolytic Viruses, and Emerging Cellular and Molecular Targets.
Emilie Alard, Aura-Bianca Butnariu, Marta Grillo, Charlotte Kirkham, Dmitry Aleksandrovich Zinovkin, Louise Newnham, Jenna Macciochi, Md Zahidul Islam Pranjol. Cancers (Basel) 2020
8
50

Immunosuppressive Effect of Exosomes from Mesenchymal Stromal Cells in Defined Medium on Experimental Colitis.
Zhi Jie Ma, Yun Hong Wang, Zhi Gang Li, Ying Wang, Bing Yao Li, Hui Yan Kang, Xiao Yun Wu. Int J Stem Cells 2019
22
50

Tumor microenvironment: Interactions and therapy.
Masoud Najafi, Nasser Hashemi Goradel, Bagher Farhood, Eniseh Salehi, Somaye Solhjoo, Heidar Toolee, Ebrahim Kharazinejad, Keywan Mortezaee. J Cell Physiol 2019
69
50

Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model.
Emily K Mader, Yoshihiro Maeyama, Yi Lin, Greg W Butler, Holly M Russell, Evanthia Galanis, Stephen J Russell, Allan B Dietz, Kah-Whye Peng. Clin Cancer Res 2009
126
50

Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice.
Álvaro Morales-Molina, Stefano Gambera, Teresa Cejalvo, Rafael Moreno, Miguel Ángel Rodríguez-Milla, Ana Judith Perisé-Barrios, Javier García-Castro. Cancer Immunol Immunother 2018
12
50

Influence of carrier cells on the clinical outcome of children with neuroblastoma treated with high dose of oncolytic adenovirus delivered in mesenchymal stem cells.
Gustavo J Melen, Lidia Franco-Luzón, David Ruano, África González-Murillo, Arantzazu Alfranca, Fernando Casco, Álvaro Lassaletta, Mercedes Alonso, Luís Madero, Ramón Alemany,[...]. Cancer Lett 2016
38
50

Delivery of LNA-antimiR-142-3p by Mesenchymal Stem Cells-Derived Exosomes to Breast Cancer Stem Cells Reduces Tumorigenicity.
Zahra Naseri, Reza Kazemi Oskuee, Mehdi Forouzandeh-Moghadam, Mahmoud Reza Jaafari. Stem Cell Rev Rep 2020
10
50

Mechanisms of measles virus oncolytic immunotherapy.
Gemma Pidelaserra-Martí, Christine E Engeland. Cytokine Growth Factor Rev 2020
8
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.